KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
KyDo Therapeutics has raised $5.3M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
KyDo Therapeutics's investors include i&i Biotech Fund, KHAN Technology Transfer Fund, VORNvc, TU capital.
KyDo Therapeutics is headquartered in Dortmund, Germany.
KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
KyDo Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KyDo Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/kydo-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). KyDo Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kydo-therapeutics
{{cite web |title=KyDo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kydo-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated